Ratings by Northland (Jason Wittes)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/5/2021 Globus Medical GMED Maintain Outperform
(N/A)
 
 
  Details
7/28/2021 Stryker SYK Upgrade Outperform
(Market Perform)
268.35
(329.45)
22.77% Details
7/1/2021 Biotricity BTCY New Coverage Outperform
(N/A)
3.15
(0.46)
-85.4% Details
5/6/2021 NuVasive NUVA Maintain Market Perform
(N/A)
 
 
  Details
4/14/2021 NovoCure Ltd. NVCR Maintain Outperform
(N/A)
 
 
  Details
4/9/2021 Zimmer Biomet ZBH Upgrade Outperform
(Market Perform)
164.54
(100.98)
-38.63% Details
3/5/2021 Alphatec Holdings ATEC Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 Stereotaxis STXS Maintain Outperform
(N/A)
 
 
  Details
2/18/2021 Globus Medical GMED Maintain Outperform
(N/A)
 
 
  Details
2/8/2021 Zimmer Biomet ZBH Maintain Market Perform
(N/A)
 
 
  Details
1/7/2021 Accuray ARAY New Coverage Outperform
(N/A)
4.88
(0.28)
-94.26% Details
10/30/2020 Stryker SYK Maintain Market Perform
(N/A)
 
 
  Details
10/20/2020 Zimmer Biomet ZBH New Coverage Market Perform
(N/A)
142.00
(100.98)
-28.89% Details
10/9/2020 Alphatec Holdings ATEC Maintain Outperform
(N/A)
 
 
  Details
10/6/2020 Stryker SYK New Coverage Market Perform
(N/A)
214.06
(329.45)
53.91% Details
9/23/2020 NovoCure Ltd. NVCR New Coverage Outperform
(N/A)
104.15
(17.10)
-83.58% Details
9/8/2020 Stereotaxis STXS New Coverage Outperform
(N/A)
3.17
(1.42)
-55.21% Details
8/6/2020 Globus Medical GMED Upgrade Outperform
(Market Perform)
50.66
(86.91)
71.56% Details
7/21/2020 Globus Medical GMED New Coverage Market Perform
(N/A)
47.83
(50.66)
5.92% Details
6/25/2020 NuVasive NUVA New Coverage Market Perform
(N/A)
54.86
(39.75)
-27.54% Details
6/18/2020 Alphatec Holdings ATEC New Coverage Outperform
(N/A)
4.88
(9.48)
94.26% Details